Hansoh Pharmaceutical (03692) Grants 11.3976 Million Restricted Share Units Under Post-IPO Restricted Share Unit Plan

Hansoh Pharma (03692) announced that on June 27, 2024, under the post-IPO Restricted Share Unit (RSU) Plan adopted by the company on May 27, 2019, RSUs representing a total of 11,397,600 shares were granted to 616 RSU grantees, subject to their acceptance. The purchase price for the granted RSUs was HKD 3.379.